Abstract | BACKGROUND:
Interleukin 17 (IL-17) is a proinflammatory cytokine produced by a new subset of activated CD4+ T cells, Th17 cells. We previously showed that increased Th17 cell populations were presented in human medulloblastoma-infiltrating T cells and peripheral blood. In this study, we attempted to address the possible role of Th17 cells in the biologic activity of IL-17 for tumor control. METHODS: We grafted fresh surgically obtained medulloblastoma into syngeneic athymic nude/nude mice. We intrapertonially injected splenocyte and murine IL-17 in mice on the second day. The tumor volume and the life spans of the mice were measured. Meanwhile, the IL-17, IL-6, IL-23, Ccl2, Ccl20 and IFN-gamma expression in the tumors was also examined by real-time PCR, Western blot and enzyme-linked immunosorbent assay. RESULTS: We found that medulloblastoma growth in IL-17-injected mice was significantly inhibited compared to the non-IL-17 treated mice. In contrast to the IL-17 antitumor activity observed in mice injected with splenocytes, we observed that IFN-gamma, IL-6, IL-23, Ccl2, and Ccl20 proteins were significantly increased in tumor tissues of mice injected with IL-17. CONCLUSIONS: These experiments suggest that IL-17 may promote splenocyte antitumor activity in medulloblastoma. We postulate that IL-17's antitumor activity may be related to the increased protein levels of IFN-gamma, IL-6, IL-23, Ccl2, and Ccl20.
|
Authors | Ping Zhou, Qilin Zhang, Yao Zhao, Hongying Sha, Xiaoyun Cao, Yongfei Wang |
Journal | European journal of medical research
(Eur J Med Res)
Vol. 20
Pg. 98
(Dec 18 2015)
ISSN: 2047-783X [Electronic] England |
PMID | 26684834
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- CCL20 protein, mouse
- Ccl2 protein, mouse
- Chemokine CCL2
- Chemokine CCL20
- Interleukin-17
- Interleukin-23
- Interleukin-6
- Interferon-gamma
|
Topics |
- Animals
- Antineoplastic Agents
(administration & dosage, pharmacology)
- Cerebellar Neoplasms
(drug therapy, genetics, pathology)
- Chemokine CCL2
(metabolism)
- Chemokine CCL20
(metabolism)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Injections
- Interferon-gamma
(metabolism)
- Interleukin-17
(administration & dosage, metabolism, pharmacology)
- Interleukin-23
(genetics)
- Interleukin-6
(genetics)
- Medulloblastoma
(drug therapy, genetics, pathology)
- Mice, Inbred BALB C
- Mice, Nude
- Spleen
(cytology)
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
|